In light of the recent and final negative FDA determination in the long and sorry chapter of the FDA VivaGel fiasco, I wonder if Starpharma will soon announce to the ASX that the licence/deal/partnership with EDW Pharma is terminated.
Or will it be another one of these tenuous and ridiculous partnerships that somehow remain ‘on foot’ (whatever that actually means) long into the future but with no credible advancement or update.
Or, will it be one of those ‘partnerships’ that just sort of disappear from view, not mentioned again, but without a formal announcement to the market?
ITF Pharma update, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $12.03K | 116.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 109616 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |